MXPA05000140A - Derivados de nocatiacina o-derivatizada. - Google Patents

Derivados de nocatiacina o-derivatizada.

Info

Publication number
MXPA05000140A
MXPA05000140A MXPA05000140A MXPA05000140A MXPA05000140A MX PA05000140 A MXPA05000140 A MX PA05000140A MX PA05000140 A MXPA05000140 A MX PA05000140A MX PA05000140 A MXPA05000140 A MX PA05000140A MX PA05000140 A MXPA05000140 A MX PA05000140A
Authority
MX
Mexico
Prior art keywords
carbon atoms
alkyl
group
mmol
ambrio
Prior art date
Application number
MXPA05000140A
Other languages
English (en)
Spanish (es)
Inventor
Joanne J Bronson
Original Assignee
Squibb Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb Bristol Myers Co filed Critical Squibb Bristol Myers Co
Publication of MXPA05000140A publication Critical patent/MXPA05000140A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MXPA05000140A 2002-07-03 2003-07-02 Derivados de nocatiacina o-derivatizada. MXPA05000140A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/189,710 US7022667B2 (en) 2002-07-03 2002-07-03 O-derivatized nocathiacin derivatives
PCT/US2003/021012 WO2004004646A2 (en) 2002-07-03 2003-07-02 O-derivatized nocathiacin derivatives

Publications (1)

Publication Number Publication Date
MXPA05000140A true MXPA05000140A (es) 2005-04-11

Family

ID=30114034

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05000140A MXPA05000140A (es) 2002-07-03 2003-07-02 Derivados de nocatiacina o-derivatizada.

Country Status (9)

Country Link
US (1) US7022667B2 (enExample)
EP (1) EP1531854A4 (enExample)
JP (1) JP2005536492A (enExample)
CN (1) CN1678340A (enExample)
AU (1) AU2003247783A1 (enExample)
BR (1) BR0312550A (enExample)
CA (1) CA2491074A1 (enExample)
MX (1) MXPA05000140A (enExample)
WO (1) WO2004004646A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4036440B2 (ja) * 2002-03-29 2008-01-23 東洋合成工業株式会社 新規な感光性化合物及び感光性樹脂並びに感光性組成物
AU2007237861B2 (en) * 2006-04-18 2012-05-10 Council Of Scientific And Industrial Research Novel antibacterial compounds
GB0609617D0 (en) * 2006-05-16 2006-06-21 Astrazeneca Ab Process & intermediate
US20080242597A1 (en) * 2006-10-20 2008-10-02 Kun Liu Antibiotic compounds
US20080132500A1 (en) * 2006-10-20 2008-06-05 Kun Liu Antibiotic compounds
WO2022149618A1 (ja) * 2021-01-06 2022-07-14 中外製薬株式会社 酸性官能基のアルキル化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1242052C (zh) 1998-07-16 2006-02-15 布里斯托尔-迈尔斯斯奎布公司 诺卡氏菌的生物纯培养物
WO2000014100A1 (en) 1998-09-04 2000-03-16 Bristol-Myers Squibb Company Nocathiacin antibiotic derivatives prepared by microbial biotransformation
US6287827B1 (en) 1999-05-05 2001-09-11 Bristol-Myers Squibb Company Halo- or hydroxy-substituted nocathiacin antibiotics
US20020055465A1 (en) 2000-08-14 2002-05-09 Wenying Li Nocathiacin antibiotics prepared by biotransformation or chemical methods
US20020065219A1 (en) * 2000-08-15 2002-05-30 Naidu B. Narasimhulu Water soluble thiazolyl peptide derivatives

Also Published As

Publication number Publication date
WO2004004646A3 (en) 2004-09-16
AU2003247783A1 (en) 2004-01-23
US7022667B2 (en) 2006-04-04
US20040018963A1 (en) 2004-01-29
WO2004004646A2 (en) 2004-01-15
JP2005536492A (ja) 2005-12-02
BR0312550A (pt) 2005-04-26
CA2491074A1 (en) 2004-01-15
EP1531854A2 (en) 2005-05-25
CN1678340A (zh) 2005-10-05
EP1531854A4 (en) 2006-06-28

Similar Documents

Publication Publication Date Title
US20020065219A1 (en) Water soluble thiazolyl peptide derivatives
RU2737892C1 (ru) Гидроксиалкилтиадиазольные производные
JP6654635B2 (ja) 新規なシストバクタミド
MXPA05000140A (es) Derivados de nocatiacina o-derivatizada.
WO2017186110A1 (zh) 一类万古霉素衍生物、其制备方法、药物组合物和用途
US4123539A (en) 6-Ethylpenicillanic acid
EP4219437B1 (en) Bakuchiol derivative, pharmaceutically acceptable salt thereof, preparation method therefor and application thereof
EP0520435A2 (en) DC-89 derivatives
US4200635A (en) Antibacterially active amides
Kamachi et al. Synthesis and biological activity of a new cephalosporin, BMY-28232 and its prodrug-type esters for oral use
EP0635479B1 (en) Perylene quinones (UCN-1028 D) derivatives
US20040058880A1 (en) Aminoglycoside antibiotics as novel anti-infective agents
JP2013542173A (ja) 新規抗菌性化合物、それらの作製法、およびそれらの使用
JPS6391398A (ja) ２０−修飾タイロシンおよびデスマイコシン化合物の新規なアシル誘導体
US4380651A (en) Process for preparing 6'-methylspectinomycin and analogs thereof
CN104803911A (zh) 一类截短侧耳素化合物、其药物组合物、合成方法与用途
US20100069449A1 (en) Novel oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient
WO2023232519A1 (en) Novel albicidin derivatives, their use and synthesis
CA3056571C (en) N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives
CZ20032426A3 (cs) Deriváty caloporosidu, léčiva s jejich obsahem, způsob přípravy těchto látek pomocí mikroorganismu a tento mikroorganismus
EP4249486A1 (en) Albicidin derivatives, their use and synthesis
JPH07500352A (ja) マクロライドの糖誘導体
AU688441B2 (en) 3-(7-oxo-1-aza-4-oxabicyclo{3.2.0}hept-3-yl) alanine derivative as antitumor agent
Bright et al. Synthesis and biological activities of 4"-deoxy-4"-sulfonamido-oleandomycin derivatives
HK40089915B (en) Bakuchiol derivative, pharmaceutically acceptable salt thereof, preparation method therefor and application thereof